Key medications that slow CKD progression: ACE inhibitors & ARBs cornerstone therapy to reduce proteinuria and protect kidney function SGLT2 inhibitors originally for diabetes, now proven to reduce CKD progression and hospitalizations for heart failure GLP-1 receptor agonists improve glycemic control and show cardiovascular and kidney benefits Non-steroidal MRAs (finerenone) a new option to reduce albuminuria and improve outcomes in diabetic CKD These therapies, when used together and tailored to the patient, represent a modern stack of treatments that can delay or even prevent kidney failure
Approval for Sleep Apnea, MASH, CKD Tirzepatide (Zepbound) originally approved for weight loss now also holds FDA approval for the treatment of moderate to severe obstructive sleep apnea in adults with obesity
Incapsula incident ID: 271000720052275591-123886416115470866
Sometimes called pseudo-sciatica, treatment differs from disc-related sciatica and focuses on piriformis stretching, soft tissue therapy, and hip alignment all areas our team addresses
This creates a dangerous "peaks-and-troughs" reality for blood pressure control, leaving patients at high cardiovascular risk
I accepted that the medicine was working for me